Is a complete SOPH research report available?

No complete published report is available for SOPHiA GENETICS SA (SOPH) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

SOPHiA GENETICS SA (SOPH)

NASDAQ: SOPH · USD

$6.05

-0.35 (-5.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SOPH analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	507.6M
Revenue (ttm)	81.2M
Net income (ttm)	-80.9M
EPS (ttm)	-$1.18
Shares out	83.9M
Volume	391,932
Beta	0.96
Price target	$9.00	+48.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 81.2M
Net income (ttm): -80.9M
EPS (ttm): -$1.18
Market cap: 507.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SOPH indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001840706
Company name	SOPHiA GENETICS SA
Country	Switzerland
Country code	US
Cusip	H82027105
Employees	415
Employees Change	-8%
Employees Change Percent	-1.89
Enterprise value	$504.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Industry PE Fwd	28.4
IPO Date	2021-07-23
Isin	CH1125843347
Last refreshed	2026-07-24
Market cap	$507.6M
Market cap category	Small-Cap
Price	$6.05
Price currency	USD
Rev Per Employee	195,614.46x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	7374
Symbol	SOPH
Website	https://www.sophiagenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.95%
EV Sales Forward	5.18x
EV/Sales	6.22x
FCF yield	-8.22%
P/B ratio	9.51x
P/S ratio	6.25x
PS Forward	5.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-88.88%
EBITDA Margin	-76.58%
Gross margin	67.28%
Gross Profit	$54.6M
Gross Profit Growth	19.41%
Gross Profit Growth Q	20.81%
Gross Profit Growth3 Y	16.84%
Gross Profit Growth5 Y	23.85%
Net Income	$-80.9M
Net Income Growth Years	0%
Pretax Margin	-98.14%
Profit Margin	-99.7%
Profit Per Employee	$-195,027
ROA	-29.71
Roa5y	-22.17
ROCE	-65.36
ROE	-123.3
Roe5y	-56.26
ROIC	-40.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	76.45%
Cagr3y	12.58%
EPS Growth Years	0
Revenue Growth	20.85x
Revenue Growth Q	21.99x
Revenue Growth Quarters	6x
Revenue Growth Years	6x
Revenue Growth3 Y	17.02x
Revenue Growth5 Y	22.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.53
Assets	$157M
Cash	$65.4M
Current Assets	$95.8M
Current Liabilities	$46.6M
Debt	$62.4M
Debt Equity	$1.37
Equity	$45.7M
Interest Coverage	-12.97
Liabilities	$111.3M
Long Term Assets	$61.2M
Long Term Liabilities	$64.7M
Net Cash	$3M
Net Cash By Market Cap	$0.58
Net Cash Growth	-92.27%
Net Debt Equity	$-0.06
Tangible Book Value	$9.9M
Tangible Book Value Per Share	$0.14
WACC	9.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.06
Inventory Turnover	4.38
Net Working Capital	$-13.5M
Quick ratio	1.71
Working Capital	$49.2M
Working Capital Turnover	$1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	76.39%
200-day SMA	4.9
3Y total return	42.69%
50-day SMA	5.33
50-day SMA vs 200-day SMA	50over200
All Time High	19.8
All Time High Change	-69.44%
All Time High Date	2021-08-31
All Time Low	1.69
All Time Low Change	259.05%
All Time Low Date	2022-11-09
ATR	0.39
Beta	0.96
Beta1y	1.1
Beta2y	1.28
Ch YTD	29.55
High	6.56
High52	6.77
High52 Date	2026-07-22
High52ch	-10.64%
Low	6.03
Low52	2.92
Low52 Date	2025-08-05
Low52ch	107.19%
Ma50ch	13.59%
Premarket Change Percent	1.88
Premarket Price	$6.52
Premarket Volume	200
Price vs 200-day SMA	23.37%
RSI	57.81
RSI Monthly	61.03
RSI Weekly	64.61
Sharpe ratio	1.12x
Sortino ratio	1.97
Total Return	-3.62%
Tr YTD	29.55
Tr1m	13.3%
Tr1w	3.77%
Tr3m	17.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$9.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.22
Earnings Revenue Estimate	21,615,500x
Earnings Revenue Estimate Growth	17.97x
Operating Income	$-72.2M
Operating margin	-88.91
Price target	$9
Price Target Change	$48.76
Price Target Change Top	$57.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	63,929,195%
Float Percent	76.2%
Net Borrowing	32,585,000
Shares Insiders	8.89%
Shares Institutions	33.19%
Shares Out	83,895,266
Shares Qo Q	3.86%
Shares Yo Y	3.62%
Short Float	1%
Short Ratio	2.13
Short Shares	0.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-57.4M
Average Volume	380,257.6x
Bv Per Share	0.64
CAPEX	$-1.5M
Ch1m	13.3
Ch1w	3.77
Ch1y	76.39
Ch3m	17.93
Ch3y	42.69
Ch6m	9.6
Change	-5.47%
Change From Open	-7.77
Close	6.4
Days Gap	2.5
Depreciation Amortization	1,859,000
Dollar Volume	2,371,188.6
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-72.2M
EBITDA	$-62.2M
EPS	$-1.18
F Score	2
FCF	$-41.7M
FCF EV Yield	-8.27x
FCF Per Share	$-0.5
Financing CF	44,209,000
Fiscal Year End	December
Founded	2,011
Income Tax	$1.3M
Investing CF	-10,212,000
Ipr	-66.39
Iprfo	-67.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	5.04
Ma150ch	20.06%
Ma20	5.8
Ma20ch	4.27%
Net CF	-3,136,000
Next Earnings Date	2026-08-04
Open	6.56
Optionable	Yes
Position In Range	3.77
Post Close	6.05
Postmarket Change Percent	-0.33
Postmarket Price	$6.03
Ppne	16,797,000
Pre Close	6.4
Price Date	2026-07-23
Ptbv Ratio	51.46
Relative Volume	1.03x
Revenue	81,180,000x
SBC By Revenue	19.32x
Share Based Comp	15,683,000
Tax By Revenue	1.55x
Tr6m	9.6%
Volume	391,932
Z Score	-3.98

SOPHiA GENETICS SA (SOPH)

Coverage state: Market snapshot only — no published research

Generate the first SOPH analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SOPH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SOPH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SOPH

Frequently asked questions